Compare ADMA Biologics Inc (ADMA) vs Autodesk Inc (ADSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Autodesk Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Autodesk Inc trades at $249.34 (market cap $53.12B). The key difference: Autodesk Inc is far larger — about 23.9× ADMA Biologics Inc's market cap, and Autodesk Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | ADSK | |
|---|---|---|
Market Cap | $2.22B | $53.12B |
Sector | Health | Technology |
52-Week High | $20.38 | $326.79 |
52-Week Low | $7.60 | $187.72 |
Enterprise Value | $2.29B | $52.92B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Autodesk Inc
Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction.
Read more on ADSK →
